How Medicare Advantage's new hospice coverage affects end-of-life care for people with Alzheimer's and related dementias

Impact of the Medicare Advantage Hospice Carve-In on End-of-life Care Outcomes among Beneficiaries with Alzheimer's Disease and Related Dementia

NIH-funded research Brown University · NIH-11191412

This project compares end-of-life care for people with Alzheimer's and related dementias before and after Medicare Advantage began covering hospice to see how hospice use and care patterns change.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBrown University NIH-funded
Lab location1 site (Providence, United States)
Project IDNIH-11191412 on NIH RePORTER

What this research studies

This project looks at how including hospice benefits inside Medicare Advantage affects people like me who have Alzheimer's or a related dementia. Researchers will use national Medicare records from before and after the policy change to compare hospice enrollment, length of stay, and rates of leaving hospice early for people with dementia. They will compare areas with high and low Medicare Advantage enrollment and counties that adopted the hospice carve-in versus those that did not, and try to separate the policy's effects from other trends over time. The goal is to show whether hospice access and the quality of end-of-life care for people with dementia changed after the carve-in and where any problems are most likely to occur.

Who could benefit from this research

Good fit: This work focuses on Medicare beneficiaries with Alzheimer's disease or related dementias, especially those enrolled in or eligible for Medicare Advantage and hospice services.

Not a fit: People who are not on Medicare, who do not have dementia, or whose care is entirely outside Medicare Advantage may not see direct benefit from this specific project.

Why it matters

Potential benefit: If successful, the findings could guide policies to keep hospice accessible and stable for people with dementia, reducing disruptive hospice disenrollments and improving comfort near the end of life.

How similar studies have performed: Prior research has documented hospice disenrollment and differences in end-of-life care for people with dementia, but analyzing the specific impact of the Medicare Advantage hospice carve-in is relatively new.

Where this research is happening

Providence, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's disease and related dementiaAlzheimer's disease and related disordersAlzheimer's disease or a related dementiaAlzheimer's disease or a related disorderAlzheimer's disease or related dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.